| Full Name | Garrett Jaffe |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 6 Years |
| Location | 24 Hospital Ave, Danbury, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003300146 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 12023680 (Connecticut) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 12.007651 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Physicians Regional Medical Center - Pine Ridge | Naples, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coastal Anesthesia And Pain Associates Pllc | 6406214196 | 4 |
| Capital Anesthesia Solutions Of Florida Ii, Llc | 7911323720 | 212 |
News Archive
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, found that a regimen of three drugs (elexacaftor/tezacaftor/ivacaftor) that targets the genetic cause of cystic fibrosis was safe and effective in 6-11-year-olds with at least one copy of F508del mutation in the CFTR gene, which is estimated to represent almost 90 percent of the cystic fibrosis population in the United States.
A new study discusses the results of a survey including well over 1.3 million participants in the UK and the USA. During the initial part of the vaccination campaign – that is, the phase including February 1, 2021 – the researchers found significantly more hesitancy towards the vaccine among Black, Asian, and Hispanic communities, as well as greater difficulty in accessing vaccines among them.
It's already May. The heat is rising in the South, and the rest of the country soon will follow. Of course this means swimsuit season, and a plan to arrive at a healthy weight will help you look good at the pool and make you healthier overall, say University of Alabama at Birmingham experts.
The first few patients have received doses of an experimental RNA-targeting drug for Huntington's disease, it was announced today.
› Verified 9 days ago
| Entity Name | Center For Sight Pl |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386718468 PECOS PAC ID: 1658340294 Enrollment ID: O20040929001217 |
News Archive
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, found that a regimen of three drugs (elexacaftor/tezacaftor/ivacaftor) that targets the genetic cause of cystic fibrosis was safe and effective in 6-11-year-olds with at least one copy of F508del mutation in the CFTR gene, which is estimated to represent almost 90 percent of the cystic fibrosis population in the United States.
A new study discusses the results of a survey including well over 1.3 million participants in the UK and the USA. During the initial part of the vaccination campaign – that is, the phase including February 1, 2021 – the researchers found significantly more hesitancy towards the vaccine among Black, Asian, and Hispanic communities, as well as greater difficulty in accessing vaccines among them.
It's already May. The heat is rising in the South, and the rest of the country soon will follow. Of course this means swimsuit season, and a plan to arrive at a healthy weight will help you look good at the pool and make you healthier overall, say University of Alabama at Birmingham experts.
The first few patients have received doses of an experimental RNA-targeting drug for Huntington's disease, it was announced today.
› Verified 9 days ago
| Entity Name | Korunda Medical, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609056282 PECOS PAC ID: 5092895334 Enrollment ID: O20071228000056 |
News Archive
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, found that a regimen of three drugs (elexacaftor/tezacaftor/ivacaftor) that targets the genetic cause of cystic fibrosis was safe and effective in 6-11-year-olds with at least one copy of F508del mutation in the CFTR gene, which is estimated to represent almost 90 percent of the cystic fibrosis population in the United States.
A new study discusses the results of a survey including well over 1.3 million participants in the UK and the USA. During the initial part of the vaccination campaign – that is, the phase including February 1, 2021 – the researchers found significantly more hesitancy towards the vaccine among Black, Asian, and Hispanic communities, as well as greater difficulty in accessing vaccines among them.
It's already May. The heat is rising in the South, and the rest of the country soon will follow. Of course this means swimsuit season, and a plan to arrive at a healthy weight will help you look good at the pool and make you healthier overall, say University of Alabama at Birmingham experts.
The first few patients have received doses of an experimental RNA-targeting drug for Huntington's disease, it was announced today.
› Verified 9 days ago
| Entity Name | Capital Anesthesia Solutions Of Florida,llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750940532 PECOS PAC ID: 7214267053 Enrollment ID: O20190923000305 |
News Archive
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, found that a regimen of three drugs (elexacaftor/tezacaftor/ivacaftor) that targets the genetic cause of cystic fibrosis was safe and effective in 6-11-year-olds with at least one copy of F508del mutation in the CFTR gene, which is estimated to represent almost 90 percent of the cystic fibrosis population in the United States.
A new study discusses the results of a survey including well over 1.3 million participants in the UK and the USA. During the initial part of the vaccination campaign – that is, the phase including February 1, 2021 – the researchers found significantly more hesitancy towards the vaccine among Black, Asian, and Hispanic communities, as well as greater difficulty in accessing vaccines among them.
It's already May. The heat is rising in the South, and the rest of the country soon will follow. Of course this means swimsuit season, and a plan to arrive at a healthy weight will help you look good at the pool and make you healthier overall, say University of Alabama at Birmingham experts.
The first few patients have received doses of an experimental RNA-targeting drug for Huntington's disease, it was announced today.
› Verified 9 days ago
| Entity Name | Capital Anesthesia Solutions Of Florida Ii, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891318481 PECOS PAC ID: 7911323720 Enrollment ID: O20200811002165 |
News Archive
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, found that a regimen of three drugs (elexacaftor/tezacaftor/ivacaftor) that targets the genetic cause of cystic fibrosis was safe and effective in 6-11-year-olds with at least one copy of F508del mutation in the CFTR gene, which is estimated to represent almost 90 percent of the cystic fibrosis population in the United States.
A new study discusses the results of a survey including well over 1.3 million participants in the UK and the USA. During the initial part of the vaccination campaign – that is, the phase including February 1, 2021 – the researchers found significantly more hesitancy towards the vaccine among Black, Asian, and Hispanic communities, as well as greater difficulty in accessing vaccines among them.
It's already May. The heat is rising in the South, and the rest of the country soon will follow. Of course this means swimsuit season, and a plan to arrive at a healthy weight will help you look good at the pool and make you healthier overall, say University of Alabama at Birmingham experts.
The first few patients have received doses of an experimental RNA-targeting drug for Huntington's disease, it was announced today.
› Verified 9 days ago
| Entity Name | Coastal Anesthesia & Pain Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144918970 PECOS PAC ID: 6406214196 Enrollment ID: O20230628002241 |
News Archive
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, found that a regimen of three drugs (elexacaftor/tezacaftor/ivacaftor) that targets the genetic cause of cystic fibrosis was safe and effective in 6-11-year-olds with at least one copy of F508del mutation in the CFTR gene, which is estimated to represent almost 90 percent of the cystic fibrosis population in the United States.
A new study discusses the results of a survey including well over 1.3 million participants in the UK and the USA. During the initial part of the vaccination campaign – that is, the phase including February 1, 2021 – the researchers found significantly more hesitancy towards the vaccine among Black, Asian, and Hispanic communities, as well as greater difficulty in accessing vaccines among them.
It's already May. The heat is rising in the South, and the rest of the country soon will follow. Of course this means swimsuit season, and a plan to arrive at a healthy weight will help you look good at the pool and make you healthier overall, say University of Alabama at Birmingham experts.
The first few patients have received doses of an experimental RNA-targeting drug for Huntington's disease, it was announced today.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Garrett Jaffe, 24 Hospital Ave, Danbury, CT 06810-6099 Ph: (203) 739-7118 | Garrett Jaffe, 24 Hospital Ave, Danbury, CT 06810 Ph: (203) 739-7118 |
News Archive
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, found that a regimen of three drugs (elexacaftor/tezacaftor/ivacaftor) that targets the genetic cause of cystic fibrosis was safe and effective in 6-11-year-olds with at least one copy of F508del mutation in the CFTR gene, which is estimated to represent almost 90 percent of the cystic fibrosis population in the United States.
A new study discusses the results of a survey including well over 1.3 million participants in the UK and the USA. During the initial part of the vaccination campaign – that is, the phase including February 1, 2021 – the researchers found significantly more hesitancy towards the vaccine among Black, Asian, and Hispanic communities, as well as greater difficulty in accessing vaccines among them.
It's already May. The heat is rising in the South, and the rest of the country soon will follow. Of course this means swimsuit season, and a plan to arrive at a healthy weight will help you look good at the pool and make you healthier overall, say University of Alabama at Birmingham experts.
The first few patients have received doses of an experimental RNA-targeting drug for Huntington's disease, it was announced today.
› Verified 9 days ago
Adam Ryan-lewis Boucher, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 860-377-4177 | |
Jennifer Park Severenko, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-739-7118 Fax: 203-749-9030 | |
Miss Jessica Burlington Hamlin, RN, MS, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-739-7000 | |
Mrs. Diana Eileen Jones, CRNA APRN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-739-7118 | |
John F O'brien, A.P.R.N. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7118 | |
Renee Nicole Rathbun, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 914-299-6785 |